Evaluation of clinical efficacy of COVID-19 vaccination in patients with hematological diseases.
Not Applicable
- Conditions
- hematological diseases
- Registration Number
- JPRN-UMIN000045267
- Lead Sponsor
- Blood Disorders Center, Aiiku Hospital
- Brief Summary
Ann Hematol. 2023 Jun;102(6):1421-1431. doi: 10.1007/s00277-023-05204-7. Ann Hematol. 2023 Apr;102(4):819-827. doi: 10.1007/s00277-023-05142-4. Br J Haematol. 2023 Mar;200(6):717-721. doi: 10.1111/bjh.18578. Br J Haematol. 2022 Nov;199(4):627-630. doi: 10.1111/bjh.18447. Br J Haematol. 2022 Jun;197(6):691-696. doi: 10.1111/bjh.18138.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 660
Inclusion Criteria
Not provided
Exclusion Criteria
Patients who are judged to be ineligible for the study.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method